XDEQ:LSE:LSE-Xtrackers MSCI World Quality UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 5538

Change

-10.50 (-0.19)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+1.58 (+0.57%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+0.75 (+0.40%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+0.21 (+0.15%)

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.13 (+0.76%)

USD 559.82B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.09 (+0.64%)

USD 500.71B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.95 (-1.42%)

USD 266.08B
0QZO:LSE 0QZO

+0.45 (+0.47%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

+0.22 (+0.75%)

USD 204.07B
0QZ3:LSE Qualcomm Inc.

+2.88 (+1.69%)

USD 202.26B

ETFs Containing XDEQ:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 16.72% 78% C+ 73% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.72% 78% C+ 74% C
Trailing 12 Months  
Capital Gain 27.85% 72% C 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 27.85% 72% C 69% C-
Trailing 5 Years  
Capital Gain 82.20% 87% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.20% 87% B+ 84% B
Average Annual (5 Year Horizon)  
Capital Gain 13.41% 76% C+ 76% C+
Dividend Return 13.41% 75% C 76% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.21% 61% D- 77% C+
Risk Adjusted Return 119.63% 98% N/A 99% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike